EGFR and cancer: GSEA results demonstrate an obvious enrichment of immunoregulatory pathways against cancer in high-risk HCC patients, such as the mTOR signaling pathway, WNT signaling pathway, ERBB signaling pathway, GNRH signaling pathway, NOTCH signaling pathway, and P53 signaling pathway.